SLC16A12 and nonpapillary renal cell carcinoma: RT-qPCR validated differential expression of WDR72, ANLN, and SLC16A12 in normal renal versus ccRCC tumor tissues, supporting their potential as diagnostic and therapeutic biomarkers.